Adiponectin level is lowered in obesity and exhibits a negative correlation with insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) [15, 16]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.